• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Inherited Metabolic Disorders Global Clinical Trials Review, H2, 2012 - Product Image

Inherited Metabolic Disorders Global Clinical Trials Review, H2, 2012

  • Published: July 2012
  • Region: Global
  • 106 pages
  • GlobalData

Inherited Metabolic Disorders Global Clinical Trials Review, H2, 2012

Summary

Our clinical trial report, “Inherited Metabolic Disorders Global Clinical Trials Review, H2, 2012" provides data on the Inherited Metabolic Disorders clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inherited Metabolic Disorders. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inherited Metabolic Disorders. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, READ MORE >

List of Tables
List of Figures
Introduction
Inherited Metabolic Disorders
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Inherited Metabolic Disorders
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Inherited Metabolic Disorders Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Genzyme Corporation
Clinical Trial Overview of Genzyme Corporation
Sanofi
Clinical Trial Overview of Sanofi
Synageva BioPharma Corp.
Clinical Trial Overview of Synageva BioPharma Corp.
Shire Plc
Clinical Trial Overview of Shire Plc
Raptor Pharmaceuticals Corp.
Clinical Trial Overview of Raptor Pharmaceuticals Corp.
Amsterdam Molecular Therapeutics (AMT) Holding N.V.
Clinical Trial Overview of Amsterdam Molecular Therapeutics (AMT) Holding N.V.
Actelion Pharmaceuticals Ltd
Clinical Trial Overview of Actelion Pharmaceuticals Ltd
U.S. Biotest Inc.
Clinical Trial Overview of U.S. Biotest Inc.
Edison Pharmaceuticals, Inc.
Clinical Trial Overview of Edison Pharmaceuticals, Inc.
Promethera Biosciences S.A.
Clinical Trial Overview of Promethera Biosciences S.A.
ReceptoPharm, Inc.
Clinical Trial Overview of ReceptoPharm, Inc.
Repligen Corporation
Clinical Trial Overview of Repligen Corporation
Zambon Company S.p.A.
Clinical Trial Overview of Zambon Company S.p.A.
Actelion Ltd
Clinical Trial Overview of Actelion Ltd
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Oregon Health and Science University
Clinical Trial Overview of Oregon Health and Science University
Masonic Cancer Center
Clinical Trial Overview of Masonic Cancer Center
Baylor College of Medicine
Clinical Trial Overview of Baylor College of Medicine
Centre Hospitalier Universitaire de Nice
Clinical Trial Overview of Centre Hospitalier Universitaire de Nice
University of California, San Diego
Clinical Trial Overview of University of California, San Diego
Children's Research Institute
Clinical Trial Overview of Children's Research Institute
The Children's Hospital Los Angeles
Clinical Trial Overview of The Children's Hospital Los Angeles
New York Medical College
Clinical Trial Overview of New York Medical College
Semmelweis University
Clinical Trial Overview of Semmelweis University
Peking University
Clinical Trial Overview of Peking University
Rennes University Hospital
Clinical Trial Overview of Rennes University Hospital
University of Leipzig
Clinical Trial Overview of University of Leipzig
Children's Hospital Boston
Clinical Trial Overview of Children's Hospital Boston
University Hospital Hamburg-Eppendorf
Clinical Trial Overview of University Hospital Hamburg-Eppendorf
Far Eastern Memorial Hospital
Clinical Trial Overview of Far Eastern Memorial Hospital
University of Sao Paulo
Clinical Trial Overview of University of Sao Paulo
Northwestern University
Clinical Trial Overview of Northwestern University
McGill University Health Center
Clinical Trial Overview of McGill University Health Center
Sheba Medical Center
Clinical Trial Overview of Sheba Medical Center
University of Louisville
Clinical Trial Overview of University of Louisville
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Inherited Metabolic Disorders Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Inherited Metabolic Disorders Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Inherited Metabolic Disorders Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, North America, Top Countries, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, BRIC Countries, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, G7 Countries, 2012-
Inherited Metabolic Disorders Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, E7 Countries, 2012-
Inherited Metabolic Disorders Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Inherited Metabolic Disorders Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Inherited Metabolic Disorders Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Inherited Metabolic Disorders Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Inherited Metabolic Disorders Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Inherited Metabolic Disorders Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Inherited Metabolic Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Synageva BioPharma Corp., 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Raptor Pharmaceuticals Corp., 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Amsterdam Molecular Therapeutics (AMT) Holding N.V., 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Pharmaceuticals Ltd, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Biotest Inc., 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Edison Pharmaceuticals, Inc., 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Promethera Biosciences S.A., 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by ReceptoPharm, Inc., 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Repligen Corporation, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Zambon Company S.p.A., 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nice, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Research Institute, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital Los Angeles, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by New York Medical College, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Semmelweis University, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Peking University, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Rennes University Hospital, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leipzig, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital Boston, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Hamburg-Eppendorf, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Far Eastern Memorial Hospital, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba Medical Center, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Louisville, 2012-

List of Figures
Inherited Metabolic Disorders Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Inherited Metabolic Disorders Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Inherited Metabolic Disorders Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, G7 Countries (%), 2012-
Inherited Metabolic Disorders Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Inherited Metabolic Disorders Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Inherited Metabolic Disorders Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Inherited Metabolic Disorders Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Inherited Metabolic Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Inherited Metabolic Disorders Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos